Press

25. Nov. 2024

Aphaia Pharma to Participate in a Panel Discussion at the 1st Annual Obesity & Metabolic Innovation Forum

ZUG, Switzerland, SAN JUAN, Puerto Rico and TORONTO, November 25, 2024 – Aphaia Pharma, a clinical-stage company harnessing precision-targeted drug formulations to restore endogenous endocrine…

Read More

16. Apr. 2024

Swiss Biotech Day

Der diesjährige Swiss Biotech Day wird mit einem Team der schweizerischen Qanatpharma AG besucht: Prof. Steffen Sebastian Bolz (Unternehmensgründer),  Dr. Philipp Trepte (Director Qanatpharma Germany),…

Read More

25. Feb. 2019

COVID-19: potential innovative therapeutic approach from Aphaia Pharma

The fight against the coronavirus (SARS-CoV-2) continues into 2021. While effective prophylaxis is now possible with vaccines, breakthrough innovations in treatment of Covid-19 patients are…

Read More